|Born||1953 (age 64–65)|
Appleton, Wisconsin, United States
|Residence||Massachusetts, United States|
|Alma mater||University of Wisconsin–Madison |
Case Western Reserve University School of Medicine
|Known for||Study of chronic traumatic encephalopathy|
|Institutions||[New England Veterans Administration Medical Centers (VISN-1) ] |
Ann McKee (born 1953) is a neuropathologist and expert in neurodegenerative disease at New England Veterans Administration Medical Centers (VISN-1) and is Professor of Neurology and Pathology at Boston University School of Medicine and Director of Boston University CTE Center. She is particularly known for her work studying Alzheimer's disease and the consequences of repetitive traumatic brain injury. In 2017, she was named Bostonian of the Year by The Boston Globefor her leading work in this area, and in 2018, Time named McKee one of its 100 most influential people.
McKee earned her bachelor's degree at the University of Wisconsin and her medical degree at Case Western Reserve University School of Medicine. McKee then completed a fellowship in neuropathology at Massachusetts General Hospital and a residency in neurology at Cleveland Metropolitan General Hospital.
McKee is the chief neuropathologist at New England Veterans Administration Medical Centers (VISN-1), and director of the Boston University CTE Center and Neuropathology Core for the Boston University Alzheimer’s Disease Center (BU ADC). Dr. McKee is also associate director of the BU ADC. Dr. McKee directs multiple brain banks including those for the BU ADC and Framingham Heart Study which are based at the Bedford VA, and the VA-BU-CLF and Chronic Effects of Neurotrauma Consortium brain banks which are based at VA Boston. Dr. McKee’s research focuses on CTE and the late-effects of traumatic neurodegeneration.
McKee is a leading authority on chronic traumatic encephalopathy (CTE), a degenerative brain disease. CTE is most commonly found in athletes participating in boxing, American football, ice hockey, other contact sports, and military service. She has found evidence of CTE in over 70 of the athletes that she has examined, including three NHL enforcers and 18 NFL players. McKee has presented her findings to National Football League officials and testified before the United States House Judiciary Committee. She has also studied diseases including Lewy Body disease, Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, frontotemporal lobar degeneration, and corticobasal degeneration.
Accolades and awards
McKee has received numerous awards in recognition of her work. In 2018, the Alzheimer's Association gave her the Henry Wisniewski Lifetime Achievement Award for her work. In the same year, Time magazine named her one of the 100 Most Influential People. Chris Borland, a former linebacker for the San Francisco 49ers who retired at the age of 24 due to brain injury concerns spurred by McKee's research, said "She may have saved my life. At the very least, her work has likely spared me much of the suffering we see today among former NFL players."
- "About - CTE Center - Boston University". Boston University. Retrieved 9 October 2018.
- "Ann McKee - CTE Center - Boston University". Boston University. Retrieved 9 October 2018.
- Swidey, Neil (December 13, 2017). "Bostonian of the Year 2017: The concussion researcher". The Boston Globe. Retrieved 19 December 2017.
- Borland, Chris. "Ann McKee is on the Time 100 2018 list". TIME Magazine. Retrieved 9 October 2018.
- "Ann McKee, MD - Alzheimer's Disease Center". Boston University. Retrieved 8 November 2014.
- Leavy, Jane (17 August 2013). "The Woman Who Would Save Football". Grantland. Retrieved 9 October 2013.
- Thompson, Helen (3 December 2012). "Evidence Mounts Linking Head Hits To Permanent Brain Injury". NPR News. Retrieved 9 October 2013.